FLAXEN
Dead / Cancelled — Cancelled — Section 8 (as of 01 Jan 2021)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85878370
- Registration number
- 4539692
- Mark type
- Stylized text
- Filed
- 18 Mar 2013
- Published for opposition
- 23 Jul 2013
- Registered
- 27 May 2014
Goods and services
- Class 005 — Pharmaceuticals: Anti-inflammatories; Anti-inflammatory and antipyretic preparations
Owner
- BELMORA, LLC, ARLINGTON, VA, US
- ALXIGNA INC, PLEASSANTON, CA, US
- Inxigna Ltd, Dover, DE, US
- Inxigna Ltd, Dover, DE, US
- Inxigna Ltd, Dover, DE, US
Prosecution history
- 01 Jan 2021 — CANCELLED SEC. 8 (6-YR)
- 27 May 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 24 Apr 2019 — NOTICE OF SUIT
- 23 Oct 2018 — NOTICE OF SUIT
- 12 Sept 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 27 Jun 2018 — NOTICE OF SUIT
- 05 Jul 2017 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 27 May 2014 — REGISTERED-PRINCIPAL REGISTER
- 24 Apr 2014 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Apr 2014 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Apr 2014 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Mar 2014 — USE AMENDMENT FILED
- 07 Apr 2014 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Mar 2014 — TEAS STATEMENT OF USE RECEIVED
- 17 Sept 2013 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT